Is MEDOF or RYLD a better dividend investment in 2026?

MEDOF currently yields 4.00% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between MEDOF and RYLD?

MEDOF has a forward dividend yield of 4.00% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 8.14 percentage points.

Home › Compare › MEDOF vs RYLD

MEDOF vs RYLD: Dividend Comparison 2026

MEDOF yields 4.00% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $18.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDOF

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$517.11

Full MEDOF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — MEDOF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDOF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDOF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDOF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDOF

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$439.54/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $1,759.70/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDOF + RYLD for your $10,000?

MEDOF: 50%RYLD: 50%

100% RYLD50/50100% MEDOF

Portfolio after 10yr

$35.2K

Annual income

$1,552.23/yr

Blended yield

4.41%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MEDOF right now

MEDOF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.2

Piotroski

5/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDOF buys

RYLD buys

No recent congressional trades found for MEDOF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDOFRYLD

Forward yield	4.00%	12.14% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$25.9K	$44.5K ✓
Annual income after 10y	$517.11	$2,587.35 ✓
Total dividends collected	$4.6K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MEDOF vs RYLD ($10,000, DRIP)

Year	MEDOF Portfolio	MEDOF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,100	$400.00	$11,914	$1,213.65	$814.00 → RYLD
2	$12,292	$414.95	$14,099	$1,351.30	$1.8K → RYLD
3	$13,582	$429.45	$16,580	$1,494.55	$3.0K → RYLD
4	$14,976	$443.47	$19,384	$1,642.61	$4.4K → RYLD
5	$16,481	$457.01	$22,535	$1,794.70	$6.1K → RYLD
6	$18,105	$470.04	$26,063	$1,950.00	$8.0K → RYLD
7	$19,855	$482.57	$29,995	$2,107.69	$10.1K → RYLD
8	$21,739	$494.59	$34,361	$2,266.99	$12.6K → RYLD
9	$23,767	$506.10	$39,194	$2,427.12	$15.4K → RYLD
10	$25,948	$517.11	$44,525	$2,587.35	$18.6K → RYLD

MEDOF vs RYLD: Complete Analysis 2026

MEDOF — Stock

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Full MEDOF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this MEDOF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDOF vs SCHD MEDOF vs JEPI MEDOF vs O MEDOF vs KO MEDOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.